For instance, Fraietta et al. observed that anti-CD19 CAR-TEFF cells from partial-responders and non-responders with CLL exhibited elevated expression of aerobic glycolysis genes and increased uptake of a glucose analog. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.